Catyalyst Pharmaceutical (CPRX) Posts Narrower than Expected Q2 Loss of 1c/Share
Tweet Send to a FriendGet Alerts CPRX Hot Sheet
Price: $0.85 -6.59%
EPS Growth %: +100.0%
Financial Fact:
Total operating costs and expenses: 1.71M
Today's EPS Names:
DSX, REDF, REX, More
EPS Growth %: +100.0%
Financial Fact:
Total operating costs and expenses: 1.71M
Today's EPS Names:
DSX, REDF, REX, More
Trade CPRX Now!
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q2 EPS of ($0.01), $0.04 better than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Compuware Corp (CPWR) Reports In-Line Q4 EPS; Guides FY14 EPS, Revs
- Analog Devices, Inc. (ADI) Reports In-Line Q2 EPS, Guidance Light
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
